| Matthew C. Busch |
Matthew C. Busch is currently working as the Chief Accounting Officer & Vice President-Finance at Amgen, Inc. He started this position in 2023. Prior to his current role, he has an education background from Brigham Young University, where he completed both undergraduate and graduate degrees. |
| David M. Reese |
David M. Reese was the founder of Translational Oncology Research International, Inc. (founded in 2003) where he served as President & Chief Medical Officer from 2003 to 2005. He currently holds the position of Chief Executive Officer at Onyx Pharmaceuticals, Inc., KAI Pharmaceuticals, Inc., Five Prime Therapeutics, Inc., ChemoCentryx, Inc., Alantos Pharmaceuticals Holding, Inc., BioVex Group, Inc., and Director at CEO Roundtable on Cancer, Inc. He is also a Director at Research!America since 2023. Previously, he worked as Director-Clinical Research at Translational Research In Oncology and Breast Cancer International Research Group Ltd. He holds an undergraduate degree from The University of Cincinnati College of Medicine and Harvard College. |
| Jean-Charles Soria |
Jean-Charles Soria is the founder of Gritstone bio, Inc. (founded in 2015). He is currently the Director-General at Institut Gustave Roussy EURL since 2017, the SVP-Research and Development at Amgen, Inc., and a Professor at Université Paris-Saclay. His former positions include being an Independent Director at HOOKIPA Pharma, Inc., Senior Vice President at MedImmune LLC and AstraZeneca PLC (2017-2019), a Member-Supervisory Board at Innate Pharma SA (2017), and an Associate Professor at The University of Texas M.D. Anderson Cancer Center (2013-2017). He also served as the Senior VP-Oncology Research & Development at AstraZeneca US from 2017 to 2019. |
| Esteban Santos |
Esteban Santos is currently working as the Executive Vice President-Operations at Amgen, Inc. He started this position in 2016. Prior to his current role, he worked at Johnson & Johnson as the General Manager-Cordis Site from 2004 to 2007. Mr. Santos has a graduate degree from Rensselaer Polytechnic Institute and an undergraduate degree from the University of Puerto Rico. |
| Darryl Sleep |
Darryl Sleep is a professional with a background in medicine. He is currently the Chief Medical Officer & Senior VP-Global Medical at Amgen, Inc. Prior to this, he worked as the Senior VP, Head-US Medical Office & Affairs at Takeda Pharmaceuticals U.S.A., Inc. from 2016 to 2018. Before that, he held positions as a Professor at the University of Pretoria, Head-Urology at Johannesburg Academic Hospital, and Academic Head-Urology Department at Kalafong Academic Hospital. Dr. Sleep received his undergraduate degree from the University of the Witwatersrand in 1983. |
| Mike Zahigian |
Mike Zahigian currently works at Amgen, Inc., as Chief Information Officer & Senior Vice President from 2017. Mr. Zahigian also formerly worked at Sourcemine, Inc., as Vice President-Technology from 2000 to 2001. Mr. Zahigian received his undergraduate degree in 1993 from the University of Southern California and Masters Business Admin degree in 2006 from Graziadio School of Business & Management. |
| Peter H. Griffith |
Peter H. Griffith's current job(s) include being a Director at Alantos Pharmaceuticals Holding, Inc., a Director at BioVex Group, Inc., and the Chief Financial Officer & Executive Vice President at Amgen, Inc. (since 2020). Mr. Griffith's former job(s) include being the Global Vice Chairman-Corporate Development at Ernst & Young Global Ltd. (2014-2019), the Managing Director & Head-Investment Banking at Wedbush Securities, Inc. (1989-1997), and the President at Sherwood Canyon Group LLC (2019). Mr. Griffith obtained his undergraduate degree from USC Marshall School of Business. |
| Nancy A. Grygiel |
Nancy A. Grygiel is currently the Director at Amgen Foundation, Inc. and the Director at United Way of Ventura County. She previously worked as the VP-Compliance, Corporate & International at Allergan, Inc. from 2011 to 2015. Ms. Grygiel's education includes a graduate degree from Universidad de Buenos Aires and Georgetown University Law Center. |
| Linda H. Louie |
Linda H. Louie is currently working as the Vice President-Finance at Amgen, Inc. She started this position in 2020 and is currently employed there. Ms. Louie holds an MBA from The Fuqua School of Business. |
| Paul Burton |
Paul Burton is currently the Chief Medical Officer at Amgen, Inc. and also holds the position of Member at the Royal College of Surgeons. Prior to his current positions, he was the Chief Global Medical Affairs Officer at Janssen Pharmaceuticals, Inc. and held the position of Vice President at Janssen Research & Development LLC. He also served as the Chief Global Medical Affairs Officer at Johnson & Johnson. Additionally, he was the Chief Medical Officer at Moderna, Inc. from 2021 to 2023. Dr. Burton holds a doctorate degree from Imperial College London and the University of London. |
| James E. Bradner |
James E. Bradner is the founder of Tensha Therapeutics, Inc. (2011), Acetylon Pharmaceuticals, Inc. (2008), C4 Therapeutics, Inc. (2015), TetraLogic Research & Development Corp. (2008), and Syros Pharmaceuticals, Inc. (2011). He is currently the Chairman at Novartis Institute for Functional Genomics, Inc., Director at Foundation for the National Institutes of Health, Inc. (starting in 2023), Chief Scientific Officer at Amgen, Inc. (starting in 2023), Associate Professor at Harvard Medical School, and Advisor at Longwood Fund Management LLC. His former positions include Associate Director-Therapeutics Science Centre at The Broad Institute, Inc., Member-Supervisory Board at QIAGEN NV (2015), Member at American Chemical Society, Member at American Society of Hematology, and President at Novartis Institutes for Biomedical Research, Inc. (2016-2022). Dr. Bradner received his undergraduate degree from Harvard University in 1994 and his doctorate from Pritzker School of Medicine. |
| Derek Miller |
Derek Miller is currently the Chief Human Resources Officer at Amgen, Inc. and the Chief Financial Officer & Senior Vice President at Southeast Alabama Medical Center. He holds an MBA from the National University of Singapore and an MBA from Anderson School of Management. He also completed his undergraduate studies at Grinnell College. |
| Robert A. Bradway |
Robert A. Bradway is currently the Chairman, President & Chief Executive Officer at Amgen, Inc. He is also the Chairman of CEO Roundtable on Cancer, Inc. and an Independent Director at The Boeing Co. He serves as a Director at W.M. Keck Foundation, Inc., Amgen Rockville, Inc., and Pharmaceutical Research & Manufacturers of America. Additionally, he is a Trustee at the University of Southern California and a Member of the American Heart Association, Inc. In his former positions, Mr. Bradway served as an Independent Director at Norfolk Southern Corp. from 2011 to 2017. He was also the Chief Financial Officer & Director at Alantos Pharmaceuticals Holding, Inc. and a Managing Director at Morgan Stanley & Co. International Plc. Prior to that, he worked as a Principal at Morgan Stanley & Co. LLC from 1987 to 2005. Mr. Bradway completed his undergraduate studies at Amherst College and holds an MBA from Harvard Business School. |
| Brian J. Druker |
Brian J. Druker is the founder of MolecularMD Corp. (founded in 2005) and Blueprint Medicines Corp. (founded in 2008). He currently holds multiple positions, including Independent Director at Amgen, Inc. since 2018, Director & Associate Dean at Oregon Health & Science University since 2010, Director at The Burroughs Wellcome Fund, Independent Director at Vincerx Pharma, Inc. since 2020, and Director at OHSU Knight Cancer Institute since 2007. Dr. Druker's education includes undergraduate and doctorate degrees from the University of California San Diego. |
| Ellen Jamison Kullman |
Ellen Jamison Kullman currently works at DuPont Argentina SRL, as Chief Executive Officer, Carbon, Inc., as Executive Chairman from 2022, Paradigm For Parity LLC, as Co-Chairman, and various other companies. Ms. Kullman also formerly worked at EIDP, Inc., as Chairman, President & Chief Executive Officer from 2009 to 2015, Axalta Coating Systems LLC, as Chairman & Chief Executive Officer, DuPont de Nemours, Inc., as Chairman & Chief Executive Officer from 2009 to 2015, and various other companies. Ms. Kullman received her undergraduate degree from Tufts University and graduate degree from Kellogg School of Management. |
| Robert Sanders Williams |
Dr. Robert S. Williams, MD, is an Independent Director at Tenaya Therapeutics, Inc., an Independent Director at Amgen, Inc., a Vice President-Research & Innovation at The University of California, San Francisco, an Independent Director at Laboratory Corp. of America Holdings, a Member at National Academy of Medicine (United States), a Professor at Duke University, a Member at American Society for Clinical Investigation, a Member at Association of American Physicians and a Member at Western Association of Physicians. He is on the Board of Directors at Tenaya Therapeutics, Inc., Amgen, Inc., Gladstone Foundation (CA), Exploratorium, The J. David Gladstone Institutes and Laboratory Corp. of America Holdings. Dr. Williams was previously employed as an Independent Director by Bristol Myers Squibb Co., a Member-Governing Board by Duke-NUS Graduate Medical School Singapore, a Dean & Senior Vice Chancellor by Duke University School of Medicine, a Chief-Cardiology & Director-Ryburn Center by The University of Texas Southwestern Medical Center, a President by Association of University Cardiologists, and an Independent Director by ESCAPE Bio, Inc. He also served on the board at The North Carolina Biotechnology Center. He received his undergraduate degree from Princeton University and a doctorate degree from Duke University. |
| Ronald D. Sugar |
Ronald D. Sugar is currently serving as the Chairman of the Pearl Harbor Memorial Fund, Chairman of Uber Technologies, Inc., Independent Director of Amgen, Inc., Independent Director of Apple, Inc., Director of the Los Angeles Philharmonic Association, Director of the UCLA Anderson School of Management, Director of Avenda Health, Inc., Director of Nexii Building Solutions, Inc., Trustee of the University of Southern California, Trustee of the Boys & Girls Clubs of America, Member of the National Academy of Engineering, Advisory Board member of Vance Street Management LLC, Advisor of Alpha Edison Management Co. LLC, and Special Advisor of Artius Management LLC. Previously, Dr. Sugar held the positions of Chairman & Chief Executive Officer of Northrop Grumman Corp., Chairman of the Aerospace Industries Association, Independent Director of Chevron Corp., President, Chief Operating Officer & Director of Litton Industries, Inc., Board of Director of Chevron Technology Ventures LLC, Director of the Los Angeles World Affairs Council, Director of Alliance College-Ready Public Schools, Director of BeyondTrust Software, Inc., Independent Director of Air Lease Corp., Chief Financial Officer of Northrop Grumman Space & Mission Systems Corp., Senior Advisor of Ares Management LLC, President & Chief Operating Officer of TRW Aerospace, and Chief Operating & Financial Officer of TRW, Inc.Dr. Sugar obtained graduate and doctorate degrees from the University of California, Los Angeles, and an undergraduate degree from the University of California, Los Angeles in 1968. |
| Amy E. Miles |
Amy E. Miles is currently serving as the Independent Non-Executive Chairman at Norfolk Southern Corp. since 2022. She is also an Independent Director at Amgen, Inc. and Gap, Inc. since 2020. Additionally, she holds director positions at Digital Cinema Implementation Partners LLC, Open Road Films LLC, Regal Foundation, and Variety of Eastern Tennessee. In 2019, she became a Director at ASM Global Parent, Inc. Previously, Ms. Miles held the position of Chairman & Chief Executive Officer at Regal Entertainment Group from 2015 to 2018. She was also the Chief Executive Officer of Regal Cinemas, Inc. from 2009 to 2018. In 2014, she served as the Vice Chairman & Executive Director at the National Association of Theatre Owners. She has also held director positions at PetSafe Brands, Townsquare Media, Inc., National CineMedia LLC, and National CineMedia, Inc. Furthermore, she served as the Treasurer & Vice President at United Artists Theatre Circuit, Inc. from 2003 to 2012. Prior to her career in the entertainment industry, she worked as a Senior Manager at PricewaterhouseCoopers LLP and Deloitte & Touche LLP. Ms. Miles completed her undergraduate degree at the University of Tennessee. |
| Greg C. Garland |
Greg C. Garland is currently the Chairman & Chief Executive Officer at Phillips 66 Co., Chairman & Chief Executive Officer at Phillips 66 Partners GP LLC, Executive Chairman at Phillips 66, Co-Chairman at The Prium (United States), Independent Director at Amgen, Inc., Director at American Petroleum Institute, Inc., Director at The National Petroleum Council, Director at Greater Houston Partnership Inc, Director at Junior Achievement of Southeast Texas, Inc., Director at Barbara Bush Houston Literacy Foundation, Member-Engineering Advisory Council at Texas A&M University, and Member-Visitors Board at The University of Texas M.D. Anderson Cancer Center. Previously, he served as President & Chief Executive Officer at Chevron Phillips Chemical Co. LLC, Chairman & Chief Executive Officer at Phillips 66 Partners LP, Director at American Chemistry Council, Inc., Director at DCP Midstream LLC (Old), Senior VP-Exploration & Americas Production at ConocoPhillips, and General Manager-Qatar & Middle East Region at Phillips Petroleum Co. He obtained his undergraduate degree from Texas A&M University in 1980. |
| Omar Syed Ishrak |
Omar Syed Ishrak is the founder of Compute Health Acquisition Corp. (founded in 2020) where he held the title of Chairman. He currently holds the position of Chairman & Chief Executive Officer at Medtronic Trading NL BV. Additionally, he is the Chairman at Biofourmis, Inc. (since 2022), Co-Chairman at Allurion Technologies, Inc. (since 2023), Independent Director at Amgen, Inc. (since 2021), Independent Director at Intel Corp. (since 2017), Director at Cargill, Inc. (since 2021), Director at Insightec Ltd. (since 2022), and Trustee at Asia Society (since 2021). Dr. Ishrak has also held former positions including Chairman & Chief Executive Officer at Medtronic, Inc. (2011-2020), President & Chief Executive Officer at Health Care Systems, Inc., President & Chief Executive Officer at Clinical Systems, Inc., President & Chief Executive Officer at GE Healthcare, Inc. (2009-2011), President & Chief Executive Officer at GE Healthcare Clinical Systems (Wisconsin) (2005-2008), and Executive Chairman at Medtronic Ltd. and Medtronic Plc (2011-2020). He has also served as a Senior Vice President at GE Aerospace, a Trustee at Minnesota Public Radio, and General Manager at Ultrasound, Inc. Dr. Ishrak received his undergraduate and doctorate degrees from King's College London. |
| Wanda M. Austin |
Wanda M. Austin founded Making Space, Inc. in 2017, where she is working as Chief Executive Officer from 2017. Dr. Austin also currently works at Hampton Roads Chapter of The American Red Cross, as Chairman from 2010, Amgen, Inc., as Independent Director from 2017, Chevron Corp., as Lead Independent Director from 2022, Horatio Alger Association of Distinguished Americans, Inc., as Director, Apple, Inc., as Director from 2024, USC Norris Comprehensive Cancer Center, as President from 2018, National Academy of Engineering, as Member, and International Academy of Astronautics, as Member. Dr. Austin also formerly worked at The Aerospace Corp., as President, Chief Executive Officer & Trustee from 2008 to 2016, The National Geographic Society, Inc., as Director, The Charles Stark Draper Laboratory, Inc., as Director, U.S. Space Foundation, as Director from 2013 to 2015, Virgin Galactic Holdings, Inc., as Independent Director from 2019 to 2023, the University of Southern California, as President from 2018 to 2019, National Aeronautics & Space Administration, as Member, The California Council on Science & Technology, as Principal from 2008 to 2013, and United States Defense Science Board, as Principal from 2010 to 2016. Dr. Austin received her graduate degree from the University of Pittsburgh, doctorate degree in 1988 from the University of Southern California, and undergraduate degree from Franklin & Marshall College. |
| Michael V. Drake |
Michael V. Drake is currently an Independent Director at Amgen, Inc., a Director at Bank of the West (California), and the President of the University of California. He previously served as Chairman of the Association of Academic Health Centers, Director of BancWest Corp. (Hawaii), Director of the California HealthCare Foundation, and Director of the Orange County Performing Art Center. He was also the President & Director of The Ohio State University Wexner Medical Center from 2014 to 2020 and the Chancellor of the University of California, Irvine from 2005 to 2014. Drake received his undergraduate degree from Stanford University and his doctorate from The University of California, San Francisco. |
| Tyler E. Jacks |
Tyler E. Jacks is the founder of T2 Biosystems, Inc. (founded in 2006) and Dragonfly Therapeutics, Inc. (founded in 2016). He currently holds positions as an Independent Director at Amgen, Inc. (since 2012), Director at Thermo Fisher Scientific, Inc. (since 2009), President & Director at Commonwealth Cancer Consortium, Inc. (since 2021), and Professor at Massachusetts Institute of Technology (since 2007). Dr. Jacks previously served as Chairman at the National Cancer Institute and as Director at the David H. Koch Institute for Integrative Cancer Research (from 2007 to 2021). He received his undergraduate degree from Harvard University in 1983 and his doctorate degree from The University of California, San Francisco in 1988. |
| Charles M. Holley |
Charles M. Holley is an Independent Director at Amgen, Inc., Phillips 66, and Carrier Global Corp. He is also a Member of the Development Board at The University of Texas at Austin, and a Member of Financial Executives International, McCombs Foundation, Inc., Texas Society of Certified Public Accountants, and The Conference Board Council of Financial Executives. Holley's former positions include Director at The Cancer Challenge, Executive Vice President at Walmart, Inc., Principal at Ernst & Young LLP, Chief Financial Officer & Senior Vice President at Wal-Mart International, and MD-European Memorex Consumer Product Division at Tandy Corp. He is also a Trustee at The First Tee. Holley received his undergraduate degree from The University of Texas at Austin and his MBA from the University of Houston. |
